CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery von Fransson, Moa, Piras, Elena, Burman, Joachim, Nilsson, Berith, Essand, Magnus, Lu, Binfeng, Harris, Robert A, Magnusson, Peetra U, Brittebo, Eva, Loskog, Angelica S I

Volltext

Immune Response Is an Important Aspect of the Antitumor Effect Produced by a CD40L-Encoding Oncolytic Adenovirus von DIACONU, Lulia, CERULLO, Vincenzo, ELIOPOULOS, Aristides G, PESONEN, Sari, HEMMINKI, Akseli, HIRVINEN, Mari L. M, ESCUTENAIRE, Sophie, UGOLINI, Matteo, PESONEN, Saila K, BRAMANTE, Simona, PARVIAINEN, Suvi, KANERVA, Anna, LOSKOG, Angelica S. I

Volltext

Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1/programmed death receptor 1, and soluble CD25 in Sokal high risk chronic myeloid leukemia von Christiansson, Lisa, Söderlund, Stina, Svensson, Emma, Mustjoki, Satu, Bengtsson, Mats, Simonsson, Bengt, Olsson-Strömberg, Ulla, Loskog, Angelica S I

Volltext

Intranasal delivery of central nervous system‐retargeted human mesenchymal stromal cells prolongs treatment efficacy of experimental autoimmune encephalomyelitis von Fransson, Moa, Piras, Elena, Wang, Hao, Burman, Joachim, Duprez, Ida, Harris, Robert A., LeBlanc, Katarina, Magnusson, Peetra U., Brittebo, Eva, Loskog, Angelica S. I.

Volltext

CAR T-Cell Therapy: The Role of Physical Barriers and Immunosuppression in Lymphoma von Enblad, Gunilla, Karlsson, Hannah, Loskog, Angelica S I

Volltext

AdCD40L Immunogene Therapy for Bladder Carcinoma— The First Phase I/IIa Trial von MALMSTRÖM, Per-Uno, LOSKOG, Angelica S. I, LINDQVIST, Camilla A, MANGSBO, Sara M, FRANSSON, Moa, WANDERS, Alkwin, GARDMARK, Truls, TÖTTERMAN, Thomas H

Volltext

T‐cell responses after haematopoietic stem cell transplantation for aggressive relapsing–remitting multiple sclerosis von Burman, Joachim, Fransson, Moa, Tötterman, Thomas H., Fagius, Jan, Mangsbo, Sara M., Loskog, Angelica S. I.

Volltext

T regulatory cells control T-cell proliferation partly by the release of soluble CD25 in patients with B-cell malignancies von Lindqvist, Camilla A, Christiansson, Lisa H, Simonsson, Bengt, Enblad, Gunilla, Olsson-Strömberg, Ulla, Loskog, Angelica S.I

Volltext

The Janus faces of CD40 in cancer von Loskog, Angelica S.I, Eliopoulos, Aristides G

Volltext

T regulatory cells in B‐cell malignancy – tumour support or kiss of death? von Lindqvist, Camilla A., Loskog, Angelica S. I.

Volltext

Both CD4+ FoxP3+ and CD4+ FoxP3− T cells from patients with B‐cell malignancy express cytolytic markers and kill autologous leukaemic B cells in vitro von Lindqvist, Camilla A., Christiansson, Lisa H., Thörn, Ingrid, Mangsbo, Sara, Paul‐Wetterberg, Gabriella, Sundström, Christer, Tötterman, Thomas H., Simonsson, Bengt, Enblad, Gunilla, Frisk, Per, Olsson‐Strömberg, Ulla, Loskog, Angelica S.I.

Volltext

AdCD40L Gene Therapy Counteracts T Regulatory Cells and Cures Aggressive Tumors in an Orthotopic Bladder Cancer Model von LOSKOG, Angelica S. I, FRANSSON, Moa E, TOTTERMAN, Thomas T. H

Volltext

T-cell pool is anergized in patients with multiple sclerosis in remission von Fransson, Moa E, Liljenfeldt, Lina S.E, Fagius, Jan, Tötterman, Thomas H, Loskog, Angelica S.I

Volltext

The cerebrospinal fluid cytokine signature of multiple sclerosis: A homogenous response that does not conform to the Th1/Th2/Th17 convention von Burman, Joachim, Svensson, Emma, Fransson, Moa, Loskog, Angelica S.I, Zetterberg, Henrik, Raininko, Raili, Svenningsson, Anders, Fagius, Jan, Mangsbo, Sara M

Volltext

Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma von Westberg, Sara, Sadeghi, Arian, Svensson, Emma, Segall, Thomas, Dimopoulou, Maria, Korsgren, Olle, Hemminki, Akseli, Loskog, Angelica S I, Tötterman, Thomas H, von Euler, Henrik

Volltext

Local CTLA4 blockade effectively restrains experimental pancreatic adenocarcinoma growth in vivo von Sandin, Linda C, Eriksson, Fredrik, Ellmark, Peter, Loskog, Angelica SI, Tötterman, Thomas H, Mangsbo, Sara M

Volltext

Enhanced therapeutic anti-tumor immunity induced by co-administration of 5-fluorouracil and adenovirus expressing CD40 ligand von Liljenfeldt, Lina, Gkirtzimanaki, Katerina, Vyrla, Dimitra, Svensson, Emma, Loskog, Angelica SI, Eliopoulos, Aristides G.

Volltext

Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up von Saellstrom, Sara, Sadeghi, Arian, Eriksson, Emma, Segall, Thomas, Dimopoulou, Maria, Korsgren, Olle, Loskog, Angelica SI, Tötterman, Thomas H., Hemminki, Akseli, Ronnberg, Henrik

Volltext

LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a no... von Musher, Benjamin L, Rowinsky, Eric K, Smaglo, Brandon G, Abidi, Wasif, Othman, Mohamed, Patel, Kalpesh, Jawaid, Salmaan, Jing, James, Brisco, Amanda, Leen, Ann M, Wu, Mengfen, Sandin, Linda C, Wenthe, Jessica, Eriksson, Emma, Ullenhag, Gustav J, Grilley, Bambi, Leja-Jarblad, Justyna, Hilsenbeck, Susan G, Brenner, Malcolm K, Loskog, Angelica S I

Volltext

Genetically engineered T cells for the treatment of cancer von Essand, M., Loskog, A. S. I.

Volltext